Paramount Health Solutions Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Paramount Health Solutions's estimated annual revenue is currently $1.1M per year.(i)
  • Paramount Health Solutions's estimated revenue per employee is $135,000

Employee Data

  • Paramount Health Solutions has 8 Employees.(i)
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$872.9M4300N/AN/AN/A
#2
$1500M5609-10%$100M$2.2B
#3
$15.5M111-7%$157.5MN/A
#4
$16M1238%N/AN/A
#5
$36.4M2285%N/AN/A
#6
$124.5M6872%N/AN/A
#7
$23.2M154-8%$60.7MN/A
#8
$317.9M15888%$332.6M$1B
#9
$22.3M140N/AN/AN/A
#10
$5.6M48N/AN/AN/A
#11
$306.2M810N/AN/AN/A
#12
$160.3M475N/AN/AN/A
#13
$79.4M4319%$10.7MN/A
#14
$80.3M47627%N/AN/A
#15
$3.5M30-9%N/AN/A
#16
$62.4M344N/AN/AN/A
#17
$48.4M163N/AN/AN/A
#18
$79.8M440-1%N/AN/A
#19
$26.8M168N/AN/AN/A
#20
$13.7M98N/AN/AN/A
Add Company

keywords:N/A

N/A

Total Funding

8

Number of Employees

$1.1M

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

Paramount Health Solutions News

2022-04-19 - Validea Peter Lynch Strategy Daily Upgrade Report - 4/23/2022

In Defense and Veterans Health Solutions market, ... PARAMOUNT GLOBAL (PARA) is a large-cap value stock in the Broadcasting & Cable TV...

2022-04-19 - Validea Peter Lynch Strategy Daily Upgrade Report - 4/23/2022

In Defense and Veterans Health Solutions market, ... PARAMOUNT GLOBAL (PARA) is a large-cap value stock in the Broadcasting & Cable TV...

2022-04-06 - National Health Priority Trends in the Democratic People's Republic ...

Housed under “communicable diseases,” infectious diseases remained the paramount health priority for the DPRK into at least 2010.

2022-04-06 - National Health Priority Trends in the Democratic People's Republic ...

Housed under “communicable diseases,” infectious diseases remained the paramount health priority for the DPRK into at least 2010.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.6M814%N/A
#2
$0.6M8N/AN/A
#3
$0.6M80%N/A
#4
$0.6M80%N/A
#5
$0.7M90%N/A